Rationale and design of the effects of EMpagliflozin on left ventricular DIAstolic function in diabetes (EmDia) study.
Journal of cardiovascular medicine (Hagerstown, Md.)(2022)
摘要
ClinicalTrials.gov; NCT02932436. Registration date, 2016/10/13.
更多查看译文
关键词
biomarkers,diastolic function,empagliflozin,SGLT2 inhibition,type 2 diabetes,vascular function
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要